Skip to main content
. 2022 Aug 6;49(13):4661–4676. doi: 10.1007/s00259-022-05918-2

Fig. 3.

Fig. 3

Meta-analysis of baseline parameters, MTV, TLG, and SUVmax for OS in studies on anti-CD20 therapy